ABBOTT LABORATORIES
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
IL
Business Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL, 60064-3500
Mailing Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL, 60064-3500
Phone
2246676100
Fiscal Year End
1231
EIN
360698440
Financial Overview
FY2025
$52.13B
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 3 Initial insider ownership report | March 25, 2026 | View on SEC |
| 4 Insider stock transaction report | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 13, 2026 | View on SEC |
Annual Reports
10-K
February 20, 2026
- Achieved robust total sales of $39.7 billion in 2024, a 3.4% increase, demonstrating resilience despite declining COVID-19 testing revenue.
- Delivered strong profitability with $7.5 billion net income and $4.30 diluted EPS in 2024, alongside $9.0 billion in operating cash flow.
Material Events
8-K
Acquisition
March 23, 2026
High Impact
- Abbott acquired Exact Sciences, a leader in cancer screening and diagnostics, known for Cologuard.
- Significantly expands Abbott's high-growth diagnostics business, especially in cancer detection and colorectal cancer screening.
Insider Trading
STRONG BUY
8 insiders
9 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.